Key clinical point: Current research supports the role of vitamin D in reducing the incidence of and death from various cancers including prostate cancer.
Major finding: Higher concentrations of 25 (OH) D were associated with reduced mortality rates, but increased incidence rates of prostate cancer in a review that included ecological, observational, and open-label studies, as well as randomized, controlled trials.
Study details: The data come from a review of recent findings on the impact of vitamin D on cancer.
Disclosures: Dr. Grant disclosed funding from Bio-Tech Pharmacal, Inc.
Grant WB. Anticancer Res. 2020. doi: 10.21873/anticanres.13977.